Literature DB >> 27744627

Sonic hedgehog signaling pathway mediates development of hepatocellular carcinoma.

Heng Cai1, Hongxing Li1, Jingmin Li1, Xiaoyan Li1, Yana Li1, Yan Shi1, Dong Wang2.   

Abstract

Although abnormal activation of the sonic hedgehog (Shh) signaling pathway has been demonstrated in human hepatocellular carcinoma (HCC) patients and in most HCC cell lines, the mechanism by which the Shh pathway promotes the development of HCC remains uncertain. Using a liver cancer model induced by diethylnitrosamine (DEN) which mimics the process from liver injury, abnormal hepatocyte proliferation, and hepatocirrhosis to hepatocyte canceration, we investigated the abnormal activation of the Shh pathway by examining the expression of Shh, patched-1 (Ptch), smoothened (SMO), and glioma-associated oncogene-1 (Gli1) genes. During this process, the expression of CDK1 and cyclin B1 protein, which are two components of the M-phase promoting factor (MPF) controlling G2/M transition, was also examined to explore the potential relationship between Shh activation and cell cycle progression. We observed that the cells with Shh, Ptch, and Gli1 protein expression were mainly distributed in hyperplastic nodule, cancerous node, the epithelia of interlobular bile duct, and precancerous tissues. A gradually increasing tendency of the positive expression rate of Shh, Ptch, and Gli1 proteins in the process from the beginning normal tissue to the final cancer formation was revealed. The cyclin B1 and CDK1 expression level was higher in the DEN-induced rats as compared with normal rats, and their expression was mainly distributed in the portal area of the liver, hyperplastic nodule, cancerous node, and precancerous tissues. Our results suggested that the Shh signaling pathway is activated during liver carcinogenesis, and activated Shh signaling promotes the cell proliferation by facilitating the G2/M transition through increasing the expression of cyclin B1 and CDK1 protein, which eventually results in the development of liver cancer. Better understanding of the Shh signaling pathway in HCC may contribute to the development of novel therapeutic strategies in inhibiting cell proliferation and promoting cell cycle arrest.

Entities:  

Keywords:  Cell cycle; DEN; Hepatocarcinoma; Sonic hedgehog

Year:  2016        PMID: 27744627     DOI: 10.1007/s13277-016-5463-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; T Vallenius; G Rijksen; T P Mäkela; R H Medema
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

2.  Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.

Authors:  Chiao-Ling Tsai; Feng-Ming Hsu; Kai-Yuan Tzen; Wei-Lin Liu; Ann-Lii Cheng; Jason Chia-Hsien Cheng
Journal:  J Gastroenterol Hepatol       Date:  2015-08       Impact factor: 4.029

3.  Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer.

Authors:  Zenichiro Saze; Masanori Terashima; Michihiko Kogure; Fumihiko Ohsuka; Hiroyuki Suzuki; Mitsukazu Gotoh
Journal:  Dig Surg       Date:  2012-03-27       Impact factor: 2.588

4.  Divergence of hedgehog signal transduction mechanism between Drosophila and mammals.

Authors:  Markku Varjosalo; Song-Ping Li; Jussi Taipale
Journal:  Dev Cell       Date:  2006-02       Impact factor: 12.270

5.  Patched1 interacts with cyclin B1 to regulate cell cycle progression.

Authors:  E A Barnes; M Kong; V Ollendorff; D J Donoghue
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

6.  Gli-1 siRNA induced apoptosis in Huh7 cells.

Authors:  Xi-Lin Chen; Liang-Qi Cao; Miao-Rong She; Qian Wang; Xiao-Hui Huang; Xin-Hui Fu
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 7.  Hedgehog signaling pathway and cancer therapeutics: progress to date.

Authors:  Joshua M Ruch; Edward J Kim
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

Review 8.  The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer.

Authors:  Alessia Omenetti; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-24       Impact factor: 4.052

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 10.  Communicating with Hedgehogs.

Authors:  Joan E Hooper; Matthew P Scott
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

View more
  11 in total

1.  Keratin 23 Is a Peroxisome Proliferator-Activated Receptor Alpha-Dependent, MYC-Amplified Oncogene That Promotes Hepatocyte Proliferation.

Authors:  Donghwan Kim; Chad N Brocker; Shogo Takahashi; Tomoki Yagai; Taehyeong Kim; Guomin Xie; Hua Wang; Aijuan Qu; Frank J Gonzalez
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

2.  Human germline hedgehog pathway mutations predispose to fatty liver.

Authors:  Maria J Guillen-Sacoto; Ariel F Martinez; Yu Abe; Paul Kruszka; Karin Weiss; Joshua L Everson; Ramon Bataller; David E Kleiner; Jerrold M Ward; Kathleen K Sulik; Robert J Lipinski; Benjamin D Solomon; Maximilian Muenke
Journal:  J Hepatol       Date:  2017-06-21       Impact factor: 25.083

Review 3.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

Review 4.  Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Authors:  Ariel F Martinez; Paul S Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-15       Impact factor: 3.908

Review 5.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

6.  Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.

Authors:  Jing Du; Weiwei Chen; Lijuan Yang; Juanjuan Dai; Jiwei Guo; Yan Wu; Kaikai Gong; Jian Zhang; Ning Yu; Zhen Xie; Sichuan Xi
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

7.  Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma.

Authors:  Qiandong Zhu; Yunpeng Sun; Qingqing Zhou; Qikuan He; Haixin Qian
Journal:  Mol Clin Oncol       Date:  2018-09-27

Review 8.  Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma.

Authors:  Kuo-Shyang Jeng; Chi-Juei Jeng; Wen-Juei Jeng; I-Shyan Sheen; Shih-Yun Li; Chuen-Miin Leu; Yeou-Guang Tsay; Chiung-Fang Chang
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

9.  CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.

Authors:  Huijie Zhuang; Gang Cao; Changhua Kou; Tao Liu
Journal:  Oncol Rep       Date:  2017-11-02       Impact factor: 3.906

10.  Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway.

Authors:  Yanmei Liu; Shujun Gao; Jie Zhu; Ya Zheng; Haiyan Zhang; Hong Sun
Journal:  Cancer Med       Date:  2018-10-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.